Trimethoprim-sulfamethoxazole treatment for meningitis owing to multidrug-resistant Elizabethkingia meningoseptica in an extremely low-birthweight, premature infant

---

Copy For Citation

Gokce I. K., ONCEL M. Y., Ozdemir R., ERDEVE O., OGUZ S. S., CANPOLAT F. E., ...More

PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, vol.32, no.3, pp.177-179, 2012 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 32 Issue: 3
• Publication Date: 2012
• Doi Number: 10.1179/2046905511y.0000000008
• Journal Name: PAEDIATRICS AND INTERNATIONAL CHILD HEALTH
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.177-179
• Inonu University Affiliated: Yes

Abstract

Elizabethkingia meningoseptica is a recognised cause of meningitis in premature neonates and severe infections in immunocompromised adults; multi-drug resistance is a major issue. A premature infant developed sepsis, meningitis and hydrocephalus owing to E. meningoseptica and was treated successfully with trimethoprim-sulfamethoxazole (TMP-SMZ) for 3 weeks. A ventriculoperitoneal shunt was required for hydrocephalus. This is the youngest patient with meningitis caused by E. meningoseptica to have responded to TMP-SMZ.